DT Investment Partners’s DexCom DXCM Stock Holding History

DT Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.8K	Hold	101	–	–	﹤0.01%	427
2026 Q1	$6.34K	Hold	101	–	–	﹤0.01%	432
2025 Q4	$6.7K	Hold	101	–	–	﹤0.01%	460
2025 Q3	$6.8K	Hold	101	–	–	﹤0.01%	450
2025 Q2	$8.82K	Hold	101	–	–	﹤0.01%	417
2025 Q1	$6.9K	Hold	101	–	–	﹤0.01%	451
2024 Q4	$7.86K	Sell	101 -315	-76%	-$23.3K	﹤0.01%	441
2024 Q3	$27.9K	Buy	416 +37	+10%	+$3.04K	﹤0.01%	315
2024 Q2	$43K	Buy	379 +315	+492%	+$39.8K	﹤0.01%	248
2024 Q1	$8.88K	Hold	64	–	–	﹤0.01%	347
2023 Q4	$7.73K	Hold	64	–	–	﹤0.01%	353
2023 Q3	$5.97K	Hold	64	–	–	﹤0.01%	357
2023 Q2	$7.81K	Hold	64	–	–	﹤0.01%	346
2023 Q1	$7.58K	Hold	64	–	–	﹤0.01%	347
2022 Q4	$7.25K	Sell	64 -2,056	-97%	-$226K	﹤0.01%	363
2022 Q3	$171K	Sell	2,120 -2,120	-50%	-$180K	0.03%	122
2022 Q2	$316K	Hold	4,240	–	–	0.05%	128
2022 Q1	$542K	Buy	4,240 +2,056	+94%	+$225K	0.07%	110
2021 Q4	$293K	Sell	2,184 -1,928	-47%	-$277K	0.04%	116
2021 Q3	$562K	Buy	+4,112	New	+$519K	0.08%	102

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DT Investment Partners's DXCM Position: Q2 2026 in Review

DT Investment Partners held its DexCom (DXCM) position steady in Q2 2026 at 101 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

DT Investment Partners first reported a position in DXCM in Q3 2021 and has held it in 20 quarters since. The position peaked at $562K in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

DT Investment Partners held 101 shares of DexCom worth $6.8K as of Q2 2026.
DT Investment Partners left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #427 holding.
DT Investment Partners first reported a position in DexCom in Q3 2021 and has held it in 20 quarters since.
DT Investment Partners's DexCom position peaked at $562K in Q3 2021.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.